Enter your Email address:
Wolters Kluwer Health may email you for journal alerts and information, but is committed
to maintaining your privacy and will not share your personal information without
You currently have no recent searches
For patients with chronic myeloid leukemia, new research says the higher their copayments for imatinib, the more likely they were to discontinue or...
Cynthia Ma's picks for the year's top studies she says are likely to shape research, and ultimately, patient care...
Trial data establish new standard of care, experts agreed.
Even though guidelines say otherwise, so a new survey finds.
What Mikkael Sekeres called "outstanding scientific research"—new drug combos, genetic sequencing, and more...
Brophy Marcus, Mary
Brophy Marcus, Mary Less
Fuerst, Mark Less
Eastman, Peggy Less
Susman, Ed Less
Samson, Kurt Less
Butcher, Lola Less
Young, Robert C.
Young, Robert C. Less
Maxwell, Sarah Less
Schrader, Joe Less
Meeting Reporter: 37th Annual San Antonio Breast Cancer SymposiumFebruary 10, 2015
Nursing Hem/Onc Spotlight SupplementApril 10, 2015, Vol. 37
All the latest news,
plus a look back at OT's comprehensive coverage on...
And for more topics in oncology, browse our full list of Article Collections!
Exclusive interviews and perspectives from our iPad archives
Most Recently Added: "How Health IT is Changing Oncology"—Andrew Zelenetz, MD, PhD, Chief of the Lymphoma Service and Vice Chair of Medical Informatics at Memorial Sloan Kettering Cancer Center, tells OT how oncologists there are training a computer to understand and compare big data sets...
February 10, 2013 - Volume 35 - SABCS Meeting Reporter Special Edition Supplement
Connect with us...
4/27/2015 ONLINE FIRST: SCLC: Evidence that Maintenance Sunitinib Can Extend Progression-Free Survival in Patients with Extensive Disease
The latest approvals, designations, and new indications from the U.S. Food and Drug Administration for oncology drugs.